LEO Pharma and PHS Capital invests in SkinVision - MarketLine Financial Deals

LEO Pharma and PHS Capital invests in SkinVision

LEO Pharma and PHS Capital invests in SkinVision - MarketLine Financial Deals
LEO Pharma and PHS Capital invests in SkinVision
Published Aug 20, 2015
2 pages — Published Aug 20, 2015
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

LEO Pharma A/S, along with PHS Capital B.V. (Personal Health Solutions (PHS) Capital), has made an equity investment in SkinVision B.V.

  
Source:
Document ID
MA158303_150825
Country
Country
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "LEO Pharma and PHS Capital invests in SkinVision" Aug 20, 2015. Alacra Store. Dec 06, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/LEO-Pharma-and-PHS-Capital-invests-in-SkinVision-2052-111975>
  
APA:
MarketLine Financial Deals. (2015). LEO Pharma and PHS Capital invests in SkinVision Aug 20, 2015. New York, NY: Alacra Store. Retrieved Dec 06, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/LEO-Pharma-and-PHS-Capital-invests-in-SkinVision-2052-111975>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.